COSTANZO, ANTONIO
COSTANZO, ANTONIO
Dipartimento di Medicina dei sistemi
308 nm monochromatic excimer light in the treatment of psoriasis
2008-01-01 Nistico', Sp; Saraceno, R; Schipani, C; Costanzo, A; Chimenti, S
A feedback regulatory loop between p63 and Dlx3: implications for epidermal differentiation
2009-04-15 Moretti, F; Costanzo, A
A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes
2005-10-20 Papoutsaki, M; Moretti, F; Lanza, M; Marinari, B; Sartorelli, V; Guerrini, L; Chimenti, S; Levrero, M; Costanzo, A
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias
2010-05-03 Moretti, F; Marinari, B; Lo Iacono, N; Botti, E; Giunta, A; Spallone, G; Garaffo, G; Vernersson Lindahl, E; Merlo, G; Mills, A; Ballarò, C; Alemà, S; Chimenti, S; Guerrini, L; Costanzo, A
A role of p73 in mitotic exit
2005-01-01 Merlo, P; Fulco, M; Costanzo, A; Mangiacasale, R; Strano, S; Blandino, G; Taya, Y; Lavia, P; Levrero, M
Actinic keratosis treated with an immune response modifier: a case report of six patients
2003-01-01 Bianchi, L; Campione, E; Marulli, Gc; Costanzo, A; Chimenti, S
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics
2007-01-01 Papoutsaki, M; Chimenti, Ms; Costanzo, A; Talamonti, M; Zangrilli, A; Giunta, A; Bianchi, L; Chimenti, S
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis
2008-01-01 Papoutsaki, M; Costanzo, A; Chimenti, Ms; Chimenti, S
Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants and
1999-01-01 De Laurenzi, V; Catani, Mv; Terrinoni, A; Corazzari, M; Melino, G; Costanzo, A; Levrero, M; Knight, R
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA
2018-01-01 Frasca, L; Palazzo, R; Chimenti, Ms; Alivernini, S; Tolusso, B; Bui, L; Botti, E; Giunta, A; Bianchi, L; Petricca, L; Auteri, Se; Spadaro, F; Fonti, Gl; Falchi, M; Evangelista, A; Marinari, B; Pietraforte, I; Spinelli, Fr; Colasanti, T; Alessandri, C; Conti, F; Gremese, E; Costanzo, A; Valesini, G; Perricone, R; Lande, R
Ascorbate up-regulates MLH1 (Mut L homologue-1) and p73: Implications for the cellular response to DNA damage
2002-01-01 Catani, Mv; Costanzo, A; Savini, I; Levrero, M; De Laurenzi, V; Wang, Jyj; Melino, G; Avigliano, L
Assessment of HLA Cw6 genotype and correlation to ustekinumab response in a large cohort of patients with moderate-to-severe psoriasis
2016-01-01 Talamonti, M; Galluzzo, M; Chimenti, S; Costanzo, A
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappa B subunits on IL-8 and Bcl-xL gene promotors
2004-01-01 Marinari, B; Costanzo, A; Marzano, V; Piccolella, E; Tuosto, L
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters
2004-04-20 Marinari, B; Costanzo, A; Marzano, V; Piccolella, E; Tuosto, L
Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain
2009-10-15 Muscolini, M; Montagni, E; Caristi, S; Nomura, T; Kamada, R; Di Agostino, S; Corazzari, M; Piacentini, M; Blandino, G; Costanzo, A; Sakaguchi, K; Tuosto, L
Claudin-1 is a p63 target gene with a crucial role in epithelial development
2008-01-01 Lopardo, T; Lo Iacono, N; Marinari, B; Giustizieri, Ml; Cyr, Dg; Merlo, G; Crosti, F; Costanzo, A; Guerrini, L
Consecutive use of different biological therapies in the treatment of psoriasis [4]
2007-01-01 Costanzo, A; Papoutsaki, M; Mazzotta, A; Chimenti, S
Cross-talks in the p53 family - Delta Np63 is an anti-apoptotci target for Delta Np73 alpha and p53 gain-of-function mutants
2006-01-01 Lanza, M; Marinari, B; Papoutsaki, M; Giustizieri, Ml; D'Alessandra, Y; Chimenti, S; Guerrini, L; Costanzo, A
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis
2012-09-01 Botti, E; Talamonti, M; Spallone, G; Galluzzo, M; Bavetta, M; Teoli, M; Pinetti, V; Costanzo, A
Delta Np63 Knockdown Mice: A Mouse Model for AEC Syndrome
2009-01-01 Koster, Mi; Marinari, B; Payne, As; Kantaputra, Pn; Costanzo, A; Roop, Dr
Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
---|---|---|---|---|
1-gen-2008 | 308 nm monochromatic excimer light in the treatment of psoriasis | Nistico', Sp; Saraceno, R; Schipani, C; Costanzo, A; Chimenti, S | Articolo su rivista | |
15-apr-2009 | A feedback regulatory loop between p63 and Dlx3: implications for epidermal differentiation | Moretti, F; Costanzo, A | Articolo su rivista | |
20-ott-2005 | A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes | Papoutsaki, M; Moretti, F; Lanza, M; Marinari, B; Sartorelli, V; Guerrini, L; Chimenti, S; Levrero, M; Costanzo, A | Articolo su rivista | |
3-mag-2010 | A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias | Moretti, F; Marinari, B; Lo Iacono, N; Botti, E; Giunta, A; Spallone, G; Garaffo, G; Vernersson Lindahl, E; Merlo, G; Mills, A; Ballarò, C; Alemà, S; Chimenti, S; Guerrini, L; Costanzo, A | Articolo su rivista | |
1-gen-2005 | A role of p73 in mitotic exit | Merlo, P; Fulco, M; Costanzo, A; Mangiacasale, R; Strano, S; Blandino, G; Taya, Y; Lavia, P; Levrero, M | Articolo su rivista | |
1-gen-2003 | Actinic keratosis treated with an immune response modifier: a case report of six patients | Bianchi, L; Campione, E; Marulli, Gc; Costanzo, A; Chimenti, S | Articolo su rivista | |
1-gen-2007 | Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics | Papoutsaki, M; Chimenti, Ms; Costanzo, A; Talamonti, M; Zangrilli, A; Giunta, A; Bianchi, L; Chimenti, S | Articolo su rivista | |
1-gen-2008 | Adalimumab for the treatment of severe psoriasis and psoriatic arthritis | Papoutsaki, M; Costanzo, A; Chimenti, Ms; Chimenti, S | Articolo su rivista | |
1-gen-1999 | Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants and | De Laurenzi, V; Catani, Mv; Terrinoni, A; Corazzari, M; Melino, G; Costanzo, A; Levrero, M; Knight, R | Articolo su rivista | |
1-gen-2018 | Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA | Frasca, L; Palazzo, R; Chimenti, Ms; Alivernini, S; Tolusso, B; Bui, L; Botti, E; Giunta, A; Bianchi, L; Petricca, L; Auteri, Se; Spadaro, F; Fonti, Gl; Falchi, M; Evangelista, A; Marinari, B; Pietraforte, I; Spinelli, Fr; Colasanti, T; Alessandri, C; Conti, F; Gremese, E; Costanzo, A; Valesini, G; Perricone, R; Lande, R | Articolo su rivista | |
1-gen-2002 | Ascorbate up-regulates MLH1 (Mut L homologue-1) and p73: Implications for the cellular response to DNA damage | Catani, Mv; Costanzo, A; Savini, I; Levrero, M; De Laurenzi, V; Wang, Jyj; Melino, G; Avigliano, L | Articolo su rivista | |
1-gen-2016 | Assessment of HLA Cw6 genotype and correlation to ustekinumab response in a large cohort of patients with moderate-to-severe psoriasis | Talamonti, M; Galluzzo, M; Chimenti, S; Costanzo, A | Intervento a convegno | |
1-gen-2004 | CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappa B subunits on IL-8 and Bcl-xL gene promotors | Marinari, B; Costanzo, A; Marzano, V; Piccolella, E; Tuosto, L | Articolo su rivista | |
20-apr-2004 | CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters | Marinari, B; Costanzo, A; Marzano, V; Piccolella, E; Tuosto, L | Articolo su rivista | |
15-ott-2009 | Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain | Muscolini, M; Montagni, E; Caristi, S; Nomura, T; Kamada, R; Di Agostino, S; Corazzari, M; Piacentini, M; Blandino, G; Costanzo, A; Sakaguchi, K; Tuosto, L | Articolo su rivista | |
1-gen-2008 | Claudin-1 is a p63 target gene with a crucial role in epithelial development | Lopardo, T; Lo Iacono, N; Marinari, B; Giustizieri, Ml; Cyr, Dg; Merlo, G; Crosti, F; Costanzo, A; Guerrini, L | Articolo su rivista | |
1-gen-2007 | Consecutive use of different biological therapies in the treatment of psoriasis [4] | Costanzo, A; Papoutsaki, M; Mazzotta, A; Chimenti, S | Articolo su rivista | |
1-gen-2006 | Cross-talks in the p53 family - Delta Np63 is an anti-apoptotci target for Delta Np73 alpha and p53 gain-of-function mutants | Lanza, M; Marinari, B; Papoutsaki, M; Giustizieri, Ml; D'Alessandra, Y; Chimenti, S; Guerrini, L; Costanzo, A | Articolo su rivista | |
1-set-2012 | Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis | Botti, E; Talamonti, M; Spallone, G; Galluzzo, M; Bavetta, M; Teoli, M; Pinetti, V; Costanzo, A | Intervento a convegno | |
1-gen-2009 | Delta Np63 Knockdown Mice: A Mouse Model for AEC Syndrome | Koster, Mi; Marinari, B; Payne, As; Kantaputra, Pn; Costanzo, A; Roop, Dr | Articolo su rivista |